1. Home
  2. KRNY vs DNA Comparison

KRNY vs DNA Comparison

Compare KRNY & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kearny Financial Corp

KRNY

Kearny Financial Corp

HOLD

Current Price

$8.06

Market Cap

511.9M

Sector

Finance

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$7.34

Market Cap

455.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRNY
DNA
Founded
1884
2008
Country
United States
United States
Employees
N/A
485
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
511.9M
455.8M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
KRNY
DNA
Price
$8.06
$7.34
Analyst Decision
Buy
Hold
Analyst Count
3
2
Target Price
$8.50
$8.50
AVG Volume (30 Days)
257.6K
978.9K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
5.33%
N/A
EPS Growth
130.22
N/A
EPS
0.30
N/A
Revenue
$2,580,000.00
N/A
Revenue This Year
$3.89
N/A
Revenue Next Year
$17.52
N/A
P/E Ratio
$27.50
N/A
Revenue Growth
36.00
N/A
52 Week Low
$5.76
$5.37
52 Week High
$8.50
$17.58

Technical Indicators

Market Signals
Indicator
KRNY
DNA
Relative Strength Index (RSI) 55.49 48.26
Support Level $7.77 $6.21
Resistance Level $8.27 $7.38
Average True Range (ATR) 0.22 0.53
MACD 0.01 0.02
Stochastic Oscillator 74.52 42.50

Price Performance

Historical Comparison
KRNY
DNA

About KRNY Kearny Financial Corp

Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: